|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Peptides derived from BH3 domains of Bcl-2 family members:a comparative analysis of inhibition of Bcl 22,Bcl-x(L) and Bax oligomerization,induction of cytochrome c release,and activation of cell death显示文摘 | Shangary S Johnson DE | 2002 | Biochemistry2002，41，30： | 1 |
| 2 | Small-molecule inhibi- tors of the MDM2-p53 protein-protein interaction to reactivate p53 function:a novel approach for cancer therapy 显示文摘 | SHANGARY S WANG S | 2009 | Annu Rev Pharmacol Toxicol2009，49，26： | 1 |
| 3 | Peptides derived from BH3 domains of Bcl-2 family members:a comparative analysis of inhibition of Bcl-2,Bcl-x(L)and Bax oligomerization,induetion of cytochrome c release,and activation of cell death显示文摘 | Johnson DE | 2002 | Biochemistry2002，41，30： | 1 |
| 4 | Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition 显示文摘 | Shangary S Qin D McEachern D | 2008 | Proc Natl Acad Sci U S A2008，105，10： | 1 |
| 5 | Potent and orally active small- molecule inhibitors of the MDM2-p53 interaction 显示文摘 | Yu S Qin D Shangary S | 2009 | J Med Chem2009，52，24： | 1 |
| 6 | Peptides derived from BH3domains of Bc I-2 family members:a comparative analysis of inhibition of Bcl-2,Bcl-x(L)and Bax oligomerization,induction of cytochrome c release,and activation of cell death显示文摘 | Shangary S Johnson DE | 2002 | Biochemistry2002，41，30： | 1 |
| 7 | Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer 显示文摘 | SHANGARY S DING K QIU S | 2008 | Mol Cancer Ther2008，7，6： | 1 |
| 8 | Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition 显示文摘 | SHANGARY S QIN D MCEACHERN D | 2008 | Proc Natl Acad Sci USA2008，105，10： | 1 |
| 9 | Peptides derived from BH3 domains of B cl-2 familymembers:a comparative analysis of inhibition of Bcl 22, Bcl-x(L)and Bax oligomerization,induction of cytochrome crelease, and activetion of cell death显示文摘 | Shangary S Johnson DE | 2002 | Biochemistry2002，41，30： | 1 |
| 10 | The cytotoxic mechanism of glyoxal in- volves oxidative stress显示文摘 | SHANGARI N BRIEN P J | 2004 | Biochemical Pharmacology2004，68，7： | 1 |
| 11 | Targeting the MDM2-p53 interaction for cancer therapy显示文摘 | Shangary S Wang S | 2008 | Clin Cancer Res2008，14，： | 1 |
| 12 | Gossypol acts directly on the mitochondria to overcome Bcl-2-and Bcl-X L mediated apoptosis resistance显示文摘 | Oliver C L Miranda M B Shangary S | 2005 | Mol Cancer Ther2005，4，1： | 1 |
| 13 | Reactivation of p53 by aspecific MDM2 antagonist( MI-43 ) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer显示文摘 | SHANGARY S DING K QIU S | 2008 | Mol Cancer Ther2008，7，： | 1 |
| 14 | Targeting the MDM2-p53 interaction for cancertherapy显示文摘 | Shangary S Wang S | 2008 | Clin Cancer Res2008，14，17： | 1 |
| 15 | Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2,Bcl-x(L) and Bax oligomerization, induction of cytochrome c release,and activation of cell death显示文摘 | Shangary S Johnson DE | 2002 | Biochemistry2002，41，30： | 1 |
| 16 | Small-molecule inhibitots of the MDM2-p53 protein-protein interaction to reactivate p53 function:a novel approach for cancer therapy显示文摘 | SHANGARY S WANG S | 2009 | Annu Rev Pharmacol Toxicol2009，49，1： | 1 |
| 17 | Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition 显示文摘 | SHANGARY S QIN D MCEACHERN D | 2008 | Proc Natl Acad Sci USA2008，105，： | 1 |
| 18 | Marginal dietary thiamin deficiency induces the formation of colonic aberrant crypt loci (ACF) in rats显示文摘 | Bruce WR Furrer R Shangari N | 2003 | Cancer Letter2003，20，： | 1 |
| 19 | Hepatocyte susceptibility to glyoxal is dependent on cell thiamin content显示文摘 | Nandita Shangari Rhea Mehta Peter J. O’Brien | 2006 | Chemico-Biological Interactions2006，，2： | 1 |
| 20 | (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance显示文摘 | Oliver CL Miranda MB Shangary S | 2005 | Mol Cancer Ther2005，4，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员